Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia.
|
16914743 |
2006 |
Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.
|
8681379 |
1996 |
Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
Identification of a SUFU germline mutation in a family with Gorlin syndrome.
|
19533801 |
2009 |
Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
The absence of typical phenotypes in this case such as palmar/plantar pits, macrocephaly, falx calcification, hypertelorism and coarse face, together with previously reported cases, suggested that individuals with NBCCS carrying a PTCH2 mutation may have a milder phenotype than those with a PTCH1 mutation.
|
23479190 |
2013 |
Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
CLINGEN |
One novel mutation, a G-->A transition (2157G-->A) in exon 15 of the PTCH2 gene, was identified in this family with NBCCS by direct sequencing and digestion with the AvaI restriction enzyme.
|
18285427 |
2008 |
Basal Cell Nevus Syndrome
|
0.770 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Congenital hydrocephalus and the basal cell nevus syndrome.
|
3986729 |
1985 |
Medulloblastoma
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
BASAL CELL CARCINOMA, SOMATIC
|
0.400 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Basal Cell Nevus Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
One novel mutation, a G-->A transition (2157G-->A) in exon 15 of the PTCH2 gene, was identified in this family with NBCCS by direct sequencing and digestion with the AvaI restriction enzyme.
|
18285427 |
2008 |
Basal Cell Nevus Syndrome
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
The absence of typical phenotypes in this case such as palmar/plantar pits, macrocephaly, falx calcification, hypertelorism and coarse face, together with previously reported cases, suggested that individuals with NBCCS carrying a PTCH2 mutation may have a milder phenotype than those with a PTCH1 mutation.
|
23479190 |
2013 |
Basal Cell Nevus Syndrome
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
One novel mutation, a G-->A transition (2157G-->A) in exon 15 of the PTCH2 gene, was identified in this family with NBCCS by direct sequencing and digestion with the AvaI restriction enzyme.
|
18285427 |
2008 |
Basal Cell Nevus Syndrome
|
0.770 |
GermlineCausalMutation
|
disease |
ORPHANET |
The absence of typical phenotypes in this case such as palmar/plantar pits, macrocephaly, falx calcification, hypertelorism and coarse face, together with previously reported cases, suggested that individuals with NBCCS carrying a PTCH2 mutation may have a milder phenotype than those with a PTCH1 mutation.
|
23479190 |
2013 |
Macrostomia
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
A susceptibility locus on 1p32-1p34 for congenital macrostomia in a Chinese family and identification of a novel PTCH2 mutation.
|
19208383 |
2009 |
Oculo-dento-digital syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
A missense mutation in PTCH2 underlies dominantly inherited NBCCS in a Chinese family.
|
18285427 |
2008 |
Oculo-dento-digital syndrome
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Frameshift mutation in the PTCH2 gene can cause nevoid basal cell carcinoma syndrome.
|
23479190 |
2013 |
Medulloblastoma
|
0.610 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinoma, Basal Cell
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Neoplasms
|
0.170 |
Biomarker
|
group |
HPO |
|
|
|
Arachnodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft upper lip
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cryptorchidism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dental caries
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Glaucoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hydrocephalus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|